Cargando…
Analysis of current status of quantitative detection of biomarkers for liver fibrosis in Clinical labs in China
AIM: To explore the quality control and implementation of the quantitative detection of liver fibrosis biomarkers, laminin (LN), collagen IV (Col Ⅳ), procollagen III amino‐terminal propeptide (PⅢNP), hyaluronic acid (HA), and cholyglycine (CG), in China. METHODS: Two quality control products were me...
Autores principales: | Zhang, Chao, Zhang, Chuanbao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9279982/ https://www.ncbi.nlm.nih.gov/pubmed/35587485 http://dx.doi.org/10.1002/jcla.24490 |
Ejemplares similares
-
Investigation of the quantitative detection of serum Helicobacter pylori antibody in clinical laboratories in China
por: Zhang, Chao, et al.
Publicado: (2021) -
Quantitative Measurement of Cancer Tissue Biomarkers in the Lab and in the Clinic
por: Carvajal-Hausdorf, Daniel, et al.
Publicado: (2014) -
Current Status of Serum Insulin and C-Peptide Measurement in Clinical Laboratories: Experience from 94 Laboratories in China
por: Zhou, Weiyan, et al.
Publicado: (2022) -
Current Strategies for Quantitating Fibrosis in Liver Biopsy
por: Wang, Yan, et al.
Publicado: (2015) -
Noninvasive serum biomarkers for liver fibrosis in NAFLD: current and future
por: Reinson, Tina, et al.
Publicado: (2023)